Eurobio Scientific (ALERS) | Stock Overview & Key Data
Eurobio Scientific Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: €29.76 on December 27, 2021
Explore how other French stocks compare to their 52-week ranges: View FR Market 52-Week Insights
Key Statistics
Financial Highlights
Annual Income Flow
2024
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Eurobio Scientific
ALERS
|
229.56M Mid-cap | 1.34% | 1.34% | 0.89% | -6.39% | -6.00% | -12.55% | 52.53% | 19.00% | 178.75% | -5.51% | -5.51% |
|
Median Technologies
ALMDT
|
188.62M Mid-cap | -3.32% | 0.00% | 2.91% | 52.78% | 12.76% | 141.21% | -23.08% | -60.40% | -44.83% | -35.48% | -35.48% |
|
Guerbet S.A
GBT
|
127.29M Small-cap | -4.57% | -1.21% | 19.63% | -27.01% | -33.63% | -53.04% | -42.84% | -67.54% | -81.86% | -38.17% | -38.17% |
|
Affluent Medical
AFME
|
122.22M Small-cap | -4.82% | 9.09% | 26.32% | 134.97% | 88.76% | 146.48% | 171.32% | -55.97% | -55.97% | -55.97% | -55.97% |
|
Mauna Kea
ALMKT
|
37.44M Small-cap | 0.00% | -5.56% | -15.00% | 142.86% | 112.50% | 30.77% | -72.58% | -72.58% | -72.58% | -72.58% | -72.58% |
|
Diagnostic Medical
ALDMS
|
34.47M Small-cap | 6.56% | 0.00% | 2.36% | 4.84% | 1.56% | 3.23% | -10.49% | -15.23% | -28.89% | -39.91% | -39.91% |
Ownership & Short Interest
Calculate Your Eurobio Scientific Investment Returns
Long-Term Investment Performance Analysis
Eurobio Scientific stock price in Jul 2016 was €7.80, A €1,000.00 lump sum investment in Eurobio Scientific made 9 years ago would be worth approximately €2,910.26 today, representing a strong return of 191.03%. This translates to an annualized return (CAGR) of 11.38%.
9 Years 10 Months Investment Scenario (Jul 2016 - Jun 2026)
Investment Breakdown
Value Comparison
Disclaimer: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing. Past performance does not guarantee future results.
Frequently Asked Questions
- What is ALERS's 52-week high and low?
- In the last 52 weeks, Eurobio Scientific reached a high of €25.95 (on July 21, 2025) and a low of €20.40 (on April 1, 2026).
- What is the market cap and P/E ratio for ALERS?
- Curious about Eurobio Scientific's size and valuation? Its market capitalization stands at 229.56M. When it comes to valuation, the P/E ratio (trailing twelve months) is 108.64, and the forward P/E (looking ahead) is 21.15.
- Does ALERS pay dividends? If so, what's the yield?
- As for dividends, Eurobio Scientific isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Eurobio Scientific's main competitors or similar companies to consider before investing?
When looking at Eurobio Scientific, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Median Technologies
ALMDT188.62M Healthcare Medical Devices 141.21% -23.08% Guerbet S.A
GBT127.29M Healthcare Medical Devices -53.04% -42.84% Affluent Medical
AFME122.22M Healthcare Medical Devices 146.48% 171.32% Mauna Kea
ALMKT37.44M Healthcare Medical Devices 30.77% -72.58% Diagnostic Medical
ALDMS34.47M Healthcare Medical Devices 3.23% -10.49% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Eurobio Scientific S.A.? (e.g., ROE, Debt/Equity)
- To get a sense of Eurobio Scientific's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 2.24%, the Debt to Equity ratio from the most recent quarter is 0.19, and its Gross Profit Margin stands at N/A.
- What is the recent revenue and earnings growth for ALERS?
- Looking at Eurobio Scientific's growth, its revenue over the trailing twelve months (TTM) was €169M. Compared to the same quarter last year (YoY), quarterly revenue grew by 8.20%, and quarterly earnings saw a YoY growth of N/A.
- How much of ALERS stock is held by insiders and institutions?
- Wondering who owns Eurobio Scientific stock? Company insiders (like executives and directors) hold about 0.09% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 97.56%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.